Zhejiang-based third-party detection service company Biozon struck a partnership with US firm Agilent Technologies. The pairing is aimed at boosting the application of inductively coupled plasma mass spectrometry (ICP-MS) technology in clinics in China, and will provide advanced clinical testing and diagnostic solutions. No financial details were disclosed.
Biozon’s Testing Programs and IVD Kits
Biozon has developed upwards of 300 testing programs covering women and children, mental health, the cardiovascular system, cancer, and others, alongside 70 in vitro diagnostic (IVD) kits.-Fineline Info & Tech
